Epidemiologic study on survival of chronic myeloid leukemia and Ph(+) acute lymphoblastic leukemia patients with BCR-ABL T315I mutation

The BCR–ABL T315I mutation represents a major mechanism of resistance to tyrosine kinase inhibitors (TKIs). The objectives of this retrospective observational study were to estimate overall and progression-free survival for chronic myeloid leukemia in chronic-phase (CP), accelerated-phase (AP), or b...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Blood
Main Authors: Nicolini, Franck E., Mauro, Michael J., Martinelli, Giovanni, Kim, Dong-Wook, Soverini, Simona, Müller, Martin C., Hochhaus, Andreas, Cortes, Jorge, Chuah, Charles, Dufva, Inge H., Apperley, Jane F., Yagasaki, Fumiharu, Pearson, Jay D., Peter, Senaka, Sanz Rodriguez, Cesar, Preudhomme, Claude, Giles, Francis, Goldman, John M., Zhou, Wei
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Hematology 2009
Assuntos:
Clinical Trials and Observations
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4916939/
https://ncbi.nlm.nih.gov/pubmed/19843886
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2009-04-219410
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados